Ebola epidemic: experimental drugs to be rushed to Africa

Vaccine trials under way as experts fear disease could become endemic in
worst-hit areas of Guinea, Sierra Leone and Liberia

*         

*        The Guardian <http://www.guardian.co.uk/theguardian> , Tuesday 23
September 2014 17.06 BST 

Medical workers n Freetown, Sierra Leone, learn how to protect themselves
against the Ebola disease. Photograph: Xinhua/Landov/Barcroft Media 

Experimental drugs are to be fast-tracked into west Africa so that they can
be tested and, if they work, save lives in the Ebola epidemic, which,
experts say, is spiralling out of control. Trials of vaccines are already in
their early stages, with healthy British volunteers taking part in safety
tests in the UK. The Wellcome Trust <http://www.wellcome.ac.uk/>  is
committing £3.2m to set up sites, systems and facilities for drug testing
across the affected countries as well.

There is major international concern over the spread of infection and the
disintegration of healthcare systems under pressure from the disease. The
Centres for Disease Control (CDC) in the US released new projections on
Tuesday saying that in the worst scenario, if the spread of Ebola goes
unchecked, there could be 1.4m cases by late January. The WHO has not
projected that far ahead, but has warned that there could be nearly 20,000
cases by early November.

Healthcare systems in the three worst-hit countries, Guinea, Sierra Leone
and Liberia, fragile to begin with, have largely collapsed under the strain
of coping with what may prove to be one of the most serious viral disease
outbreaks in modern times.

More than 40 British military and humanitarian staff have arrived in
Freetown, Sierra Leone, to oversee the construction of a UK medical
facility, which will be part of the £100m UK commitment to help contain the
outbreak. That includes 700 Ebola treatment beds.

The news followed a meeting of the UK’s emergency committee, Cobra, on
Tuesday afternoon. It was chaired by foreign secretary Philip Hammond by
videolink from New York, where the Ebola crisis had been a significant topic
of discussion. “It is now vital that the international community translates
its concern into action,” said Hammond. “This outbreak has wide-ranging
humanitarian and security consequences for the region, and the world.
Defeating this disease will need a global coalition, as well as innovative
approaches to reducing the spread of the virus in communities.”

An analysis of the first nine months of the outbreak in the New England
Journal of Medicine <http://www.nejm.org/doi/full/10.1056/NEJMoa1411100>
shows that the death rate is 70%, not 50%, when deaths outside hospitals are
counted. Many people are too frightened to go to hospital and the number of
infections is doubling every few weeks. As of 20 September, the WHO said
there had been 5,843 cases and 2,803 confirmed deaths
<http://apps.who.int/iris/bitstream/10665/134449/1/roadmapupdate22sept14_eng
.pdf?ua=1> .

Some questioned the CDC projection of 1.4m cases by January. “It’s a big
assumption that nothing will change in the current outbreak response,” said
Dr Armand Sprecher, an infectious disease specialist at Doctors Without
Borders. “Ebola outbreaks usually end when people stop touching the sick.
The outbreak is not going to end tomorrow, but there are things we can do to
reduce the case count.”

A call from the UK government for NHS volunteers to go out and help has so
far led to 164 healthcare staff signing up. A similar appeal at the London
School of Hygiene and Tropical Medicine by its director, Professor Peter
Piot, has resulted in 35 staff volunteering so far. There is a particular
need for trained nurses, clinicians, diagnostic laboratory technicians and
sanitation experts, Piot told the school.

Experts fear that Ebola could become endemic in west Africa, instead of a
viral disease that emerges from animals to cause outbreaks and then
disappears again. If that happens, the region could be a reservoir for the
spread of the virus, not only to other parts of Africa, but also the rest of
the world, said Piot and Jeremy Farrar, the director of the Wellcome Trust,
in the New England Journal
<http://www.nejm.org/doi/full/10.1056/NEJMe1411471> . They said the epidemic
“seems out of control and has evolved into a major humanitarian crisis”. In
west Africa “there is a very real danger of a complete breakdown in civic
society”, and communities have lost faith in authority.

Societies that were being rebuilt after civil war have been devastated by
Ebola and will need rebuilding once the epidemic is finally under control,
said Piot, who believes the World Health Organisation has been too slow to
respond. It was three months before the first cases in December last year
were identified, he said. “It was another five months and 1,000 deaths until
WHO declared this a public health emergency and the world started getting
serious about it.”

Several different potential drugs are likely to be trialled in west Africa,
including Zmapp, which has already been used on foreign doctors and aid
workers with the disease. Current supplies of the drug, made from leaves of
the tobacco plant, have been used up, but its manufacture is restarting.

Independent experts will decide which potential drugs are suitable for
testing – there will have to be safety data before any can be given to
patients and a rapid ethical review will have to be undertaken.

“It is a huge challenge to carry out clinical trials under such difficult
conditions, but ultimately this is the only way we will ever find out
whether any new Ebola treatments actually work,” said Farrar. “What’s more,
rapid trials, followed by large-scale manufacturing and distribution of any
effective treatments, might produce medicines that could be used in this
epidemic. The Wellcome Trust funding will allow these trials to happen
quickly, and in an ethically and scientifically robust setting.”

                 Thé Mulindwas Communication Group
"With Yoweri Museveni, Ssabassajja and Dr. Kiiza Besigye, Uganda is in
anarchy"
                    Kuungana Mulindwa Mawasiliano Kikundi
"Pamoja na Yoweri Museveni, Ssabassajja na Dk. Kiiza Besigye, Uganda ni
katika machafuko"

 

_______________________________________________
Ugandanet mailing list
[email protected]
http://kym.net/mailman/listinfo/ugandanet

UGANDANET is generously hosted by INFOCOM http://www.infocom.co.ug/

All Archives can be found at http://www.mail-archive.com/[email protected]/

The above comments and data are owned by whoever posted them (including 
attachments if any). The List's Host is not responsible for them in any way.
---------------------------------------

Reply via email to